{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:41:05Z","timestamp":1792874465464,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172628"],"award-info":[{"award-number":["82172628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974371"],"award-info":[{"award-number":["81974371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31701108"],"award-info":[{"award-number":["31701108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002503"],"award-info":[{"award-number":["82002503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173081"],"award-info":[{"award-number":["82173081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gallbladder cancer (GBC) is a highly aggressive malignant cancer in the biliary system with poor prognosis. XPO1 (chromosome region maintenance 1 or CRM1) mediates the nuclear export of several proteins, mainly tumor suppressors. Thus, XPO1 functions as a pro-oncogenic factor. KPT-330 (Selinexor) is a United States Food and Drug Administration approved selective inhibitor of XPO1 that demonstrates good therapeutic effects in hematologic cancers. However, the function of XPO1 and the effect of KPT-330 have not been reported in GBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the correlation between XPO1 expression levels by q-PCR and clinical features of GBC patients. Cell proliferation assays were used to analyze the in vitro antitumor effects of XPO1 inhibitor KPT-330. mRNA sequencing was used to explore the underlying mechanisms. Western blot was performed to explore the relationship between apoptosis and autophagy. The in vivo antitumor effect of KPT-330 was investigated in a nude mouse model of gallbladder cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that high expression of XPO1 was related to poor prognosis of GBC patients. We observed that XPO1 inhibitor KPT-330 inhibited the proliferation of GBC cells in vitro. Furthermore, XPO1 inhibitor KPT-330 induced apoptosis by reducing the mitochondrial membrane potential and triggering autophagy in NOZ and GBC-SD cells. Indeed, XPO1 inhibitor KPT-330 led to nuclear accumulation of p53 and activated the p53\/mTOR pathway to regulate autophagy-dependent apoptosis. Importantly, KPT-330 suppressed tumor growth with no obvious toxic effects in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>XPO1 may be a promising prognostic indicator for GBC, and KPT-330 appears to be a potential drug for treating GBC effectively and safely.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03635-w","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:03:27Z","timestamp":1664532207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53\/mTOR pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Cheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-9358","authenticated-orcid":false,"given":"Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"3635_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/967472","volume":"2015","author":"R Kanthan","year":"2015","unstructured":"Kanthan R, Senger J-L, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st Century. J Oncol. 2015;2015: 967472.","journal-title":"J Oncol"},{"key":"3635_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","volume":"27","author":"U Dutta","year":"2012","unstructured":"Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol. 2012;27:642\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"3635_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872\u20136.","journal-title":"Nat Genet"},{"key":"3635_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15:168\u201381.","journal-title":"Oncologist"},{"key":"3635_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-020-03286-z","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Yuan R, Ren T, Yang B, Miao H, Liu L, et al. Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps. Cell Death Dis. 2021;12:30.","journal-title":"Cell Death Dis"},{"key":"3635_CR6","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, et al. Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555\u201367.","journal-title":"Lancet Glob Health"},{"key":"3635_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1182\/blood.2020009013","volume":"137","author":"JP Abeykoon","year":"2021","unstructured":"Abeykoon JP, Wu X, Nowakowski KE, Dasari S, Paludo J, Weroha SJ, et al. Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair. Blood. 2021;137:513\u201323.","journal-title":"Blood"},{"key":"3635_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40164-015-0002-5","volume":"4","author":"A Das","year":"2015","unstructured":"Das A, Wei G, Parikh K, Liu D. Selective inhibitors of nuclear export (SINE) in hematological malignancies. Exp Hematol Oncol. 2015;4:7.","journal-title":"Exp Hematol Oncol"},{"key":"3635_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-021-02044-z","volume":"40","author":"L Pan","year":"2021","unstructured":"Pan L, Cheng C, Duan P, Chen K, Wu Y, Wu Z. XPO1\/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. J Exp Clin Cancer Res. 2021;40:255.","journal-title":"J Exp Clin Cancer Res"},{"key":"3635_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","volume":"13","author":"NG Azizian","year":"2020","unstructured":"Azizian NG, Li Y. XPO1-dependent nuclear export as a target for cancer therapy. J Hematol Oncol. 2020;13:61.","journal-title":"J Hematol Oncol"},{"key":"3635_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pharmthera.2015.06.001","volume":"153","author":"J Ishizawa","year":"2015","unstructured":"Ishizawa J, Kojima K, Hail N Jr, Tabe Y, Andreeff M. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol Ther. 2015;153:25\u201335.","journal-title":"Pharmacol Ther"},{"key":"3635_CR12","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-09-0484","volume":"69","author":"JG Turner","year":"2009","unstructured":"Turner JG, Marchion DC, Dawson JL, Emmons MF, Hazlehurst LA, Washausen P, et al. Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition. Cancer Res. 2009;69:6899\u2013905.","journal-title":"Cancer Res"},{"key":"3635_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/bjc.1996.415","volume":"74","author":"ES Newlands","year":"1996","unstructured":"Newlands ES, Rustin GJ, Brampton MH. Phase I trial of elactocin. Br J Cancer. 1996;74:648\u20139.","journal-title":"Br J Cancer"},{"key":"3635_CR14","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1021\/acs.jmedchem.1c01145","volume":"64","author":"S Liu","year":"2021","unstructured":"Liu S, Qiao W, Sun Q, Luo Y. Chromosome Region Maintenance 1 (XPO1\/CRM1) as an anticancer target and discovery of its inhibitor. j Med Chem. 2021;64:15534\u201348.","journal-title":"j Med Chem"},{"key":"3635_CR15","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.212285299","volume":"99","author":"D Daelemans","year":"2002","unstructured":"Daelemans D, Afonina E, Nilsson J, Werner G, Kjems J, De Clercq E, et al. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc Natl Acad Sci U S A. 2002;99:14440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3635_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.chembiol.2014.11.015","volume":"22","author":"JE Neggers","year":"2015","unstructured":"Neggers JE, Vercruysse T, Jacquemyn M, Vanstreels E, Baloglu E, Shacham S, et al. Identifying drug-target selectivity of small-molecule CRM1\/XPO1 inhibitors by CRISPR\/Cas9 genome editing. Chem Biol. 2015;22:107\u201316.","journal-title":"Chem Biol"},{"key":"3635_CR17","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.1016\/j.bmc.2008.09.051","volume":"16","author":"T Van Neck","year":"2008","unstructured":"Van Neck T, Pannecouque C, Vanstreels E, Stevens M, Dehaen W, Daelemans D. Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action. Bioorg Med Chem. 2008;16:9487\u201397.","journal-title":"Bioorg Med Chem"},{"key":"3635_CR18","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/nar\/gkp1137","volume":"38","author":"PJ Cock","year":"2010","unstructured":"Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa\/Illumina FASTQ variants. Nucleic Acids Res. 2010;38:1767\u201371.","journal-title":"Nucleic Acids Res"},{"key":"3635_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3635_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"3635_CR21","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"M Kanehisa","year":"2008","unstructured":"Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008;36:D480-484.","journal-title":"Nucleic Acids Res"},{"key":"3635_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4161\/auto.19471","volume":"8","author":"J Han","year":"2012","unstructured":"Han J, Pan XY, Xu Y, Xiao Y, An Y, Tie L, et al. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy. 2012;8:812\u201325.","journal-title":"Autophagy"},{"key":"3635_CR23","doi-asserted-by":"publisher","first-page":"17730","DOI":"10.1038\/srep17730","volume":"5","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, He W, Gao X, Li B, Mei C, Xu R, et al. Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9\/G NSCLC cells. Sci Rep. 2015;5:17730.","journal-title":"Sci Rep"},{"key":"3635_CR24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/jcmm.17202","volume":"26","author":"M-D Wu","year":"2022","unstructured":"Wu M-D, Zhang Y-Y, Yi S-Y, Sun B-B, Lan J, Jiang H-M, et al. Acetylshikonin induces autophagy-dependent apoptosis through the key LKB1-AMPK and PI3K\/Akt-regulated mTOR signalling pathways in HL-60 cells. J Cell Mol Med. 2022;26:1606.","journal-title":"J Cell Mol Med"},{"key":"3635_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2021.100147","volume":"12","author":"X Wei","year":"2021","unstructured":"Wei X, Tang Z, Wu H, Zuo X, Dong H, Tan L, et al. Biofunctional magnesium-coated Ti6Al4V scaffolds promote autophagy-dependent apoptosis in osteosarcoma by activating the AMPK\/mTOR\/ULK1 signaling pathway. Mater Today Bio. 2021;12: 100147.","journal-title":"Mater Today Bio"},{"key":"3635_CR26","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1038\/s41467-021-27124-8","volume":"12","author":"S Hume","year":"2021","unstructured":"Hume S, Grou CP, Lascaux P, D\u2019Angiolella V, Legrand AJ, Ramadan K, et al. The NUCKS1-SKP2-p21\/p27 axis controls S phase entry. Nat Commun. 2021;12:6959.","journal-title":"Nat Commun"},{"key":"3635_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00866-19","author":"M Gruffaz","year":"2019","unstructured":"Gruffaz M, Yuan H, Meng W, Liu H, Bae S, Kim J-S, et al. CRISPR-Cas9 screening of Kaposi\u2019s sarcoma-associated herpesvirus-transformed cells identifies XPO1 as a vulnerable target of cancer cells. mBio. 2019. https:\/\/doi.org\/10.1128\/mBio.00866-19.","journal-title":"mBio"},{"key":"3635_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.fct.2018.10.030","volume":"122","author":"B Cheng","year":"2018","unstructured":"Cheng B, Lu J, Li T, Meng Z, Liu M, Sun M, et al. 1,3-Dichloro-2-Propanol inhibits autophagy via P53\/AMPK\/mTOR pathway in HepG2 cells. Food Chem Toxicol. 2018;122:143\u201350.","journal-title":"Food Chem Toxicol"},{"key":"3635_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12967-021-03056-1","volume":"19","author":"J Zhu","year":"2021","unstructured":"Zhu J, Ao H, Liu M, Cao K, Ma J. UBE2T promotes autophagy via the p53\/AMPK\/mTOR signaling pathway in lung adenocarcinoma. J Transl Med. 2021;19:374.","journal-title":"J Transl Med"},{"key":"3635_CR30","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/leu.2008.348","volume":"23","author":"E Drakos","year":"2009","unstructured":"Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, et al. Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia. 2009;23:784\u201390.","journal-title":"Leukemia"},{"key":"3635_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0092-8674(00)80926-5","volume":"92","author":"M Ohno","year":"1998","unstructured":"Ohno M, Fornerod M, Mattaj IW. Nucleocytoplasmic transport: the last 200 nanometers. Cell. 1998;92:327\u201336.","journal-title":"Cell"},{"key":"3635_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41375-021-01483-z","volume":"36","author":"SK Balasubramanian","year":"2022","unstructured":"Balasubramanian SK, Azmi AS, Maciejewski J. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms. Leukemia. 2022;36:601.","journal-title":"Leukemia"},{"key":"3635_CR33","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1002\/ijc.30840","volume":"141","author":"W Link","year":"2017","unstructured":"Link W, Fernandez-Marcos PJ. FOXO transcription factors at the interface of metabolism and cancer. Int J Cancer. 2017;141:2379\u201391.","journal-title":"Int J Cancer"},{"key":"3635_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2017.11.009","volume":"147","author":"C Corno","year":"2018","unstructured":"Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, et al. FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models. Biochem Pharmacol. 2018;147:93\u2013103.","journal-title":"Biochem Pharmacol"},{"key":"3635_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1182\/blood-2005-05-2123","volume":"107","author":"A Aloisi","year":"2006","unstructured":"Aloisi A, Di Gregorio S, Stagno F, Guglielmo P, Mannino F, Sormani MP, et al. BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B. Blood. 2006;107:1591\u20138.","journal-title":"Blood"},{"key":"3635_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12272-017-0990-2","volume":"41","author":"L Cui","year":"2018","unstructured":"Cui L, Bu W, Song J, Feng L, Xu T, Liu D, et al. Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway. Arch Pharm Res. 2018;41:299\u2013313.","journal-title":"Arch Pharm Res"},{"key":"3635_CR37","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1158\/0008-5472.CAN-15-1572","volume":"76","author":"H Sun","year":"2016","unstructured":"Sun H, Lin DC, Cao Q, Guo X, Marijon H, Zhao Z, et al. CRM1 inhibition promotes cytotoxicity in ewing sarcoma cells by repressing EWS-FLI1-Dependent IGF-1 signaling. Cancer Res. 2016;76:2687\u201397.","journal-title":"Cancer Res"},{"key":"3635_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00280-014-2495-8","volume":"74","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Gery S, Sun H, Shacham S, Kauffman M, Koeffler HP. KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2014;74:487\u201395.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3635_CR39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1158\/1078-0432.CCR-16-1333","volume":"23","author":"Y Chen","year":"2017","unstructured":"Chen Y, Camacho SC, Silvers TR, Razak ARA, Gabrail NY, Gerecitano JF, et al. Inhibition of the nuclear export receptor XPO1 as a therapeutic target for platinum-resistant ovarian cancer. Clin Cancer Res. 2017;23:1552\u201363.","journal-title":"Clin Cancer Res"},{"key":"3635_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41408-021-00409-3","volume":"11","author":"E Boons","year":"2021","unstructured":"Boons E, Nogueira TC, Dierckx T, Menezes SM, Jacquemyn M, Tamir S, et al. XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis. Blood Cancer J. 2021;11:27.","journal-title":"Blood Cancer J"},{"key":"3635_CR41","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1002\/ptr.7321","volume":"35","author":"J Wang","year":"2021","unstructured":"Wang J, Liu G, Li X, Huangfu M, Liu Y, Li X, et al. Curcumol simultaneously induces both apoptosis and autophagy in human nasopharyngeal carcinoma cells. Phytother Res. 2021;35:7004\u201317.","journal-title":"Phytother Res"},{"key":"3635_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.746890","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zhang T, Chen G, Geng N, Guo Z, Cao S, et al. Non-Structural Protein 3 of Duck Tembusu virus induces autophagy the ERK and PI3K-AKT-mTOR signaling pathways. Front Immunol. 2022;13: 746890.","journal-title":"Front Immunol"},{"key":"3635_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.707","volume":"12","author":"P Xu","year":"2022","unstructured":"Xu P, Zhang X, Cao J, Yang J, Chen Z, Wang W, et al. The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2\/MET\/mTOR axis. Clin Transl Med. 2022;12: e707.","journal-title":"Clin Transl Med"},{"key":"3635_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117596","volume":"258","author":"Z Pan","year":"2021","unstructured":"Pan Z, Cheng D-D, Wei X-J, Li S-J, Guo H, Yang Q-C. Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53\/mTOR pathway in osteosarcoma. Carbohydr Polym. 2021;258: 117596.","journal-title":"Carbohydr Polym"},{"key":"3635_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41419-021-03449-6","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang H, Hu C, Wu C, Wang J, Hu F, et al. Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell Death Dis. 2021;12:164.","journal-title":"Cell Death Dis"},{"key":"3635_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuro.2021.05.008","volume":"85","author":"S-C Fu","year":"2021","unstructured":"Fu S-C, Lin J-W, Liu J-M, Liu S-H, Fang K-M, Su C-C, et al. Arsenic induces autophagy-dependent apoptosis via Akt inactivation and AMPK activation signaling pathways leading to neuronal cell death. Neurotoxicology. 2021;85:133\u201344.","journal-title":"Neurotoxicology"},{"key":"3635_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1158\/1078-0432.CCR-21-2225","volume":"28","author":"AB Lassman","year":"2022","unstructured":"Lassman AB, Wen PY, van den Bent MJ, Plotkin SR, Walenkamp AME, Green AL, et al. A Phase II study of the efficacy and safety of oral selinexor in recurrent glioblastoma. Clin Cancer Res. 2022;28:452\u201360.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03635-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:07:36Z","timestamp":1664539656000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03635-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3635"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03635-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments involving nude mice met the requirements and were approved by Xinhua Hospital of Shanghai Jiao Tong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have seen and approved the manuscript and consent publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}